Celox Extends the Offer on Medicover.STOCKHOLM Stockholm (stŏk`hôlm'), city (1995 pop. 692,954), capital of Sweden and of Stockholm co., E Sweden, situated where Lake Mälaren flows into the Baltic Sea. , Sweden Sweden, Swed. Sverige, officially Kingdom of Sweden, constitutional monarchy (2005 est. pop. 9,002,000), 173,648 sq mi (449,750 sq km), N Europe, occupying the eastern part of the Scandinavian peninsula. -- Medicover Holding S.A. (STO STO Store (calculator function) STO Société de Transport de l'Outaouais (French) STO Strategic Technology Office (DARPA) STO Security Through Obscurity STO Service to Others :MCOV MCOV Maximum Continuous Operating Voltage MCOV Maximum Continuous Overvoltage ): --Celox reaches 70.7% of shares and votes in Medicover --The acceptance period is extended until 1 September 2006 Celox S.A. ("Celox") has reached 70.7% of the shares and votes in Medicover Holding S.A. ("Medicover"). In total, Celox has increased its ownership with 5,075,083 shares, representing 35.6% of the shares and votes in Medicover. This has been achieved by tendered shares into the offer of 3,819,930 shares, representing 26.8% of the shares and votes in Medicover and that Celox has acquired 1,255,153 shares, representing 8.8% of the shares and votes in Medicover. Settlement for shares duly tendered by 18 August 2006, is expected to commence on 1 September 2006. To facilitate further acceptances under the offer, the acceptance period is extended until 15.00 (CET CET abbr. Central European Time CET Central European Time CET n abbr (= Central European Time) → hora de Europa central CET abbr ) 1 September 2006. This facilitates for shareholders in Medicover that have not yet tendered their shares, e.g. due to the holiday season, with the opportunity to accept the offer. Settlement after this subsequent offer period is expected to commence on 5 September 2006. Celox will consider a delisting Delisting When the stock of a company is removed from a stock exchange. Notes: Reasons for delisting include violating regulations and/or failure to meet financial specifications set out by the stock exchange. of Medicover following the end of the offer process. "We are very pleased with the acceptance level and our increased ownership in Medicover. We continue to believe that the company is best developed in a private environment. This has been supported by many shareholders, whom also have decided to continue to support Medicover in a private environment." says Fredrik Stenmo, Director at Celox S.A. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion